ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $89,254 | -6.3% | 4,356 | -9.1% | 0.05% | -3.6% |
Q2 2023 | $95,217 | +25.2% | 4,792 | +7.9% | 0.06% | +33.3% |
Q1 2023 | $76,074 | -36.8% | 4,441 | -27.8% | 0.04% | -33.3% |
Q4 2022 | $120,434 | -23.3% | 6,154 | -37.6% | 0.06% | 0.0% |
Q3 2022 | $157,000 | +16.3% | 9,860 | +0.7% | 0.06% | +26.0% |
Q2 2022 | $135,000 | +25.0% | 9,792 | +44.2% | 0.05% | +4.2% |
Q1 2022 | $108,000 | -31.2% | 6,792 | -5.6% | 0.05% | -18.6% |
Q4 2021 | $157,000 | +16.3% | 7,192 | +59.6% | 0.06% | 0.0% |
Q3 2021 | $135,000 | -35.7% | 4,506 | -4.8% | 0.06% | -31.4% |
Q2 2021 | $210,000 | -11.8% | 4,734 | -11.7% | 0.09% | -14.9% |
Q1 2021 | $238,000 | -17.6% | 5,361 | +1.9% | 0.10% | -15.8% |
Q4 2020 | $289,000 | -25.7% | 5,261 | -69.0% | 0.12% | -41.2% |
Q3 2020 | $389,000 | -3.7% | 16,995 | -12.0% | 0.20% | +6.8% |
Q2 2020 | $404,000 | +76.4% | 19,310 | +17.6% | 0.19% | +103.2% |
Q1 2020 | $229,000 | -46.5% | 16,415 | -12.7% | 0.09% | +34.3% |
Q4 2019 | $428,000 | +135.2% | 18,806 | +20.1% | 0.07% | +89.2% |
Q3 2019 | $182,000 | -26.6% | 15,663 | -5.3% | 0.04% | -28.8% |
Q2 2019 | $248,000 | -20.5% | 16,535 | -7.1% | 0.05% | -92.2% |
Q1 2019 | $312,000 | +7.2% | 17,799 | -9.2% | 0.66% | +1228.0% |
Q4 2018 | $291,000 | -45.7% | 19,604 | -10.0% | 0.05% | -9.1% |
Q3 2018 | $536,000 | -27.7% | 21,774 | -42.3% | 0.06% | -91.6% |
Q2 2018 | $741,000 | – | 37,750 | – | 0.66% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |